RIGEL PHARMACEUTICALS, INC. Operating Lease, Liability, Noncurrent
RIGEL PHARMACEUTICALS, INC. (RIGL) had Operating Lease, Liability, Noncurrent of $58.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-04
- 2026-06-30: Operating Lease, Liability, Noncurrent $58.00K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $228.00K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $395.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $556.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $58.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $228.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $395.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $556.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $714.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $864.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-03 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $285.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $466.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $628.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $802.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | $972.00K 10-K · filed 2024-03-05 |
| 2021-12-31 | $759.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $3.31M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $5.85M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $8.30M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $10.65M 10-K · filed 2022-03-01 |
| 2020-09-30 | $12.93M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $15.25M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $17.30M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $19.23M 10-K · filed 2021-03-02 |
| 2019-09-30 | $21.18M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $23.09M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $24.95M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |